ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-8Q17002
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
BUY CHAPTERS

Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2025

Code: QYRE-Auto-8Q17002
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Pfizer Inc
Novartis
Eli Lilly and Company
LEO Pharma
Astrazeneca plc
Incyte
Jiangsu Hengrui Pharmaceuticals
Suzhou Zelgen Biopharmaceuticals

Small Molecule Targeted Drugs for Allergic Diseases Market

The global market for Small Molecule Targeted Drugs for Allergic Diseases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
North American market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Molecule Targeted Drugs for Allergic Diseases in Atopic Dermatitis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Molecule Targeted Drugs for Allergic Diseases include AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals, Suzhou Zelgen Biopharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Drugs for Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Drugs for Allergic Diseases.
The Small Molecule Targeted Drugs for Allergic Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Targeted Drugs for Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Drugs for Allergic Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Small Molecule Targeted Drugs for Allergic Diseases Market Report

Report Metric Details
Report Name Small Molecule Targeted Drugs for Allergic Diseases Market
Segment by Type
  • JAK
  • TYK2
Segment by Application
  • Atopic Dermatitis
  • Asthma
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals, Suzhou Zelgen Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Small Molecule Targeted Drugs for Allergic Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecule Targeted Drugs for Allergic Diseases Market report?

Ans: The main players in the Small Molecule Targeted Drugs for Allergic Diseases Market are AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Small Molecule Targeted Drugs for Allergic Diseases Market report?

Ans: The Applications covered in the Small Molecule Targeted Drugs for Allergic Diseases Market report are Atopic Dermatitis, Asthma, Others

What are the Type segmentation covered in the Small Molecule Targeted Drugs for Allergic Diseases Market report?

Ans: The Types covered in the Small Molecule Targeted Drugs for Allergic Diseases Market report are JAK, TYK2

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 JAK
1.2.3 TYK2
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Atopic Dermatitis
1.3.3 Asthma
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Perspective (2020-2031)
2.2 Global Small Molecule Targeted Drugs for Allergic Diseases Growth Trends by Region
2.2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Targeted Drugs for Allergic Diseases Market Dynamics
2.3.1 Small Molecule Targeted Drugs for Allergic Diseases Industry Trends
2.3.2 Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
2.3.3 Small Molecule Targeted Drugs for Allergic Diseases Market Challenges
2.3.4 Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Revenue
3.1.1 Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Targeted Drugs for Allergic Diseases Revenue
3.4 Global Small Molecule Targeted Drugs for Allergic Diseases Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Drugs for Allergic Diseases Revenue in 2024
3.5 Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases, Product and Application
3.7 Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Drugs for Allergic Diseases Breakdown Data by Type
4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2026-2031)
5 Small Molecule Targeted Drugs for Allergic Diseases Breakdown Data by Application
5.1 Global Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size (2020-2031)
6.2 North America Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
6.4 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size (2020-2031)
7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
7.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size (2020-2031)
9.2 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.1.4 AbbVie Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.2.4 Pfizer Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.3.4 Novartis Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.4.4 Eli Lilly and Company Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.4.5 Eli Lilly and Company Recent Development
11.5 LEO Pharma
11.5.1 LEO Pharma Company Details
11.5.2 LEO Pharma Business Overview
11.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.5.4 LEO Pharma Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.5.5 LEO Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.6.4 AstraZeneca Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Incyte
11.7.1 Incyte Company Details
11.7.2 Incyte Business Overview
11.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.7.4 Incyte Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.7.5 Incyte Recent Development
11.8 Jiangsu Hengrui Pharmaceuticals
11.8.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.8.4 Jiangsu Hengrui Pharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.8.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.9 Suzhou Zelgen Biopharmaceuticals
11.9.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.9.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.9.4 Suzhou Zelgen Biopharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
11.9.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Pfizer Inc
Novartis
Eli Lilly and Company
LEO Pharma
Astrazeneca plc
Incyte
Jiangsu Hengrui Pharmaceuticals
Suzhou Zelgen Biopharmaceuticals
List of Tables
 Table 1. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of JAK
 Table 3. Key Players of TYK2
 Table 4. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2020-2025)
 Table 8. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2026-2031)
 Table 10. Small Molecule Targeted Drugs for Allergic Diseases Market Trends
 Table 11. Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
 Table 12. Small Molecule Targeted Drugs for Allergic Diseases Market Challenges
 Table 13. Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
 Table 14. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Players (2020-2025)
 Table 16. Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Drugs for Allergic Diseases as of 2024)
 Table 17. Ranking of Global Top Small Molecule Targeted Drugs for Allergic Diseases Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Small Molecule Targeted Drugs for Allergic Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases, Headquarters and Area Served
 Table 20. Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases, Product and Application
 Table 21. Global Key Players of Small Molecule Targeted Drugs for Allergic Diseases, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2020-2025)
 Table 25. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2026-2031)
 Table 27. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2020-2025)
 Table 29. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2026-2031)
 Table 31. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Company Details
 Table 47. AbbVie Business Overview
 Table 48. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 49. AbbVie Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Recent Development
 Table 51. Pfizer Company Details
 Table 52. Pfizer Business Overview
 Table 53. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 54. Pfizer Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 59. Novartis Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Eli Lilly and Company Company Details
 Table 62. Eli Lilly and Company Business Overview
 Table 63. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 64. Eli Lilly and Company Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 65. Eli Lilly and Company Recent Development
 Table 66. LEO Pharma Company Details
 Table 67. LEO Pharma Business Overview
 Table 68. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 69. LEO Pharma Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 70. LEO Pharma Recent Development
 Table 71. AstraZeneca Company Details
 Table 72. AstraZeneca Business Overview
 Table 73. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 74. AstraZeneca Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 75. AstraZeneca Recent Development
 Table 76. Incyte Company Details
 Table 77. Incyte Business Overview
 Table 78. Incyte Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 79. Incyte Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 80. Incyte Recent Development
 Table 81. Jiangsu Hengrui Pharmaceuticals Company Details
 Table 82. Jiangsu Hengrui Pharmaceuticals Business Overview
 Table 83. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 84. Jiangsu Hengrui Pharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 85. Jiangsu Hengrui Pharmaceuticals Recent Development
 Table 86. Suzhou Zelgen Biopharmaceuticals Company Details
 Table 87. Suzhou Zelgen Biopharmaceuticals Business Overview
 Table 88. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product
 Table 89. Suzhou Zelgen Biopharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 90. Suzhou Zelgen Biopharmaceuticals Recent Development
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. Authors List of This Report


List of Figures
 Figure 1. Small Molecule Targeted Drugs for Allergic Diseases Picture
 Figure 2. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Type: 2024 VS 2031
 Figure 4. JAK Features
 Figure 5. TYK2 Features
 Figure 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Application: 2024 VS 2031
 Figure 8. Atopic Dermatitis Case Studies
 Figure 9. Asthma Case Studies
 Figure 10. Others Case Studies
 Figure 11. Small Molecule Targeted Drugs for Allergic Diseases Report Years Considered
 Figure 12. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region: 2024 VS 2031
 Figure 15. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Players in 2024
 Figure 16. Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Drugs for Allergic Diseases as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Small Molecule Targeted Drugs for Allergic Diseases Revenue in 2024
 Figure 18. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 20. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 24. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2020-2031)
 Figure 32. China Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 40. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 44. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AbbVie Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 48. Pfizer Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 49. Novartis Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 50. Eli Lilly and Company Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 51. LEO Pharma Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 53. Incyte Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 54. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 55. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Targeted Drugs for Allergic Diseases Market Research Report 2025
Global Janus Kinase inhibitors JAKi Market Research Report 2024
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Global TYK2 Targeting Drugs Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024
Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030
Global Janus Kinase Inhibitors Market Research Report 2024
Tyrosine Kinase JAK Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
JAK1 Inhibitor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Jakinibs Market Insights Forecast to 2030
Global Anti allergic Drugs Market Research Report 2025
Global Single target MET TKIs Market Research Report 2024
Global Oral JAK Inhibitors Market Research Report 2024
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Small Molecule Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Small Molecule Drug Market Research Report 2025
Global TKIs for Breast Cancer Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions